Retreatment in patients with psoriasis achieving response with etanercept after relapse due to treatment interruption: results from the <scp>CRYSTEL</scp> study — Christopher Em Griffiths (2014) | RDL Network
Retreatment in patients with psoriasis achieving response with etanercept after relapse due to treatment interruption: results from the <scp>CRYSTEL</scp> study
Patients achieving the stringent criteria of PGA ≤ 1 with ETN therapy before ceasing treatment, and subsequently relapsing, were able to quickly regain response during retreatment. The majority of patients considered their therapy to be satisfactory.
Maria Teresa Petrucci, Pilar Giraldo, Paolo Corradini, Adriana Teixeira, Meletios A Dimopoulos, Igor Wolfgang Blau, Johannes Drach, Ralf Angermund, Nathalie Allietta, Esther Broer, Vivien Mitchell, Joan Bladé
Georgina V. Long, Ina Nordman, Christopher Steer, Megan Lyle, Claudia Trojaniello, Paolo A. Ascierto, Célèste Lebbé, Shahneen Sandhu, Alison M. Weppler, Laetitia Da Meda, Inês Pires da Silva, Wen Xu, Giovanni Grignani, Alexander M. Menzies, Matteo S. Carlino
Discussion(0)
No comments yet. Be the first to comment.